Oppenheimer & Co. Inc. Cuts Position in Abbott Laboratories (NYSE:ABT)

Oppenheimer & Co. Inc. lessened its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 3.2% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 103,199 shares of the healthcare product maker’s stock after selling 3,442 shares during the quarter. Oppenheimer & Co. Inc.’s holdings […]

Related Keywords

Canada ,Lisad Earnhardt ,Roberte Funck , ,Royal Bank ,Abbott Laboratories ,Alliance Wealth Advisors ,Securities Exchange Commission ,Goldman Sachs Group ,Citigroup ,Berger Financial Group Inc ,Oppenheimer Co ,Barclays ,Renaissance Investment Group ,Rappaport Reiches Capital Management ,Free Report ,Wealth Advisors ,Reiches Capital Management ,Financial Group Inc ,Investment Group ,Get Free Report ,Exchange Commission ,Established Pharmaceutical Products ,Diagnostic Products ,Nutritional Products ,Abbott Laboratories Daily ,